Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2026-03-01 @ 6:29 AM
Study NCT ID:
NCT04588220
Status:
UNKNOWN
Last Update Posted:
2020-10-19
First Post:
2020-10-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Melatonin, Soluble Urokinase-type Plasminogen Activator Receptor, and Orosomucoid 2 Levels in PPROM
Sponsor:
Cengiz Gokcek Women's and Children's Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-07
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-10-08
First Submit QC Date:
None
Study First Post Date:
2020-10-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-08
Last Update Post Date:
2020-10-19
Last Update Post Date Type:
ACTUAL